BIAcore Analysis to Test Phosphopeptide-SH2 Domain Interactions

  • Frédéric Vély
  • Alain Trautmann
  • Eric Vivier
Part of the Methods in Molecular Biology book series (MIMB, volume 121)


The elucidation of intracytoplasmic signaling pathways is a ctriical step in the precise understanding of cell biology. In this regard, the identification of intracytoplasmic domains, which are specialized in the transmission of biological messages, has been an enormous breakthrough (1). Among these transducing domains, the src homology 2 (SH2) domains are specialized in the interaction with the phosphorylated forms of tyrosine residues (2). SH2 domains are classically 100 amino acids long and the three-dimensional structure of several SH2-containing molecules has been resolved. As it is precisely controlled by a subtle balance between protein tyrosine kinases (which phosphorylate) and protein tyrosine phosphatases (which dephosphorylate), the phosphorylation on tyrosine residues is a highly versatile way of dictating the interaction between a given protein and an SH2-containing partner (3). The inhibitory receptors (IRs) for major histocompatibility complex (MHC) class Ia and Ib molecules expressed on NK cells, such as the killer cell inhibitory receptors (KIRs) and the CD94-NKG2A heterodimers, respectively, mediate their inhibitory function via intracytoplasmic motifs (IVLS)xYxx(LV), the immunoreceptor tyrosine-based inhibitory motifs (ITIMs) (34, 6). Upon engagement of these IRs, the tyrosine residue present in ITIMs is phosphorylated, and is therefore capable of interacting with two distinct SH2-containing proteins: the protein tyrosine phosphatases SHP-1 and SHP-2 . In this chapter, we provide protocols (1) to investigate the direct binding of recombinant soluble SH2 domains to phosphorylated peptides using surface plasmon reso-nance (SPR) technology, as well as (2) to measure the affinity constant that characterizes this interaction (7, 8, 9, 10, 11, 12, 13).


Sensor Chip Immobilize Ligand Intracytoplasmic Domain BIAevaluation Software Killer Cell Inhibitory Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Pawson T. and Scott J. D. (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science 278, 2075–2080.PubMedCrossRefGoogle Scholar
  2. 2.
    Songyang Z. and Cantley L. C. (1995) Recognition and specificity in protein tyrosine kinase-mediated signalling. TIBS 20, 470.PubMedGoogle Scholar
  3. 3.
    Schlessinger J. and Ullrich A. (1992) Growth factor signaling by receptor tyrosine kinases. Neuron 9, 383–391.PubMedCrossRefGoogle Scholar
  4. 4.
    Vivier E. and Daëron M. (1997) Immunoreceptor Tyrosine-based Inhibition Motifs (ITIMs). Immunol. Today 18, 286–291.PubMedCrossRefGoogle Scholar
  5. 5.
    Burshtyn D. N. and Long E. O. (1997) Regulation through inhibitory receptors: lessons from natural killer cells. Trends Cell. Biol. 7, 473–479.PubMedCrossRefGoogle Scholar
  6. 6.
    Leibson P. J. (1997) Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 6, 655–661.PubMedCrossRefGoogle Scholar
  7. 7.
    Bu J-Y., Shaw A. S., and Chan A. C. (1995) Analysis of the interaction of ZAP-70 and syk protein-tyrosine kinases with the T-cell antigen receptor by plasmon resonance. Proc. Natl. Acad. Sci. USA 92, 5106–5110.PubMedCrossRefGoogle Scholar
  8. 8.
    Labadia M. E., Ingraham R. H., Schembri-King J., Morelock M. M., and Jakrs S. (1996) Binding affinities of the SH2 domains of ZAP-70, p56lck and Shc to the ζ chain ITAMs of the T-cell receptor determined by surface plasmon resonance. J. Leukoc. Biol. 59, 740–746.PubMedGoogle Scholar
  9. 9.
    Jackson D. E., Kupcho K. R., and Newman P. J. (1997) Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2. J. Biol. Chem. 272, 24,868–24,875.PubMedCrossRefGoogle Scholar
  10. 10.
    Vély F., Nunès J. A., Malissen B., and Hedgecock C. J. R. (1997) Analysis of immunoreceptor tyrosine-based activation motif (ITAM) binding to ZAP-70 by surface plasmon resonance. Eur. J. Immunol. 27, 3010–3014.PubMedCrossRefGoogle Scholar
  11. 11.
    Vély F., Olivero S., Olcese L., Moretta A., Damen J. E., Liu L., Krystal G., Cambier J. C., Daëron M., and Vivier E. (1997) Differential association of phosphatases with hematopoietic co-receptors bearing immunoreceptor tyrosine-based inhibition motifs. Eur. J. Immunol. 27, 1994–2000.PubMedCrossRefGoogle Scholar
  12. 12.
    Olcese L., Lang P., Vély F., Cambiaggi A., Marguet D., Blery M., Hippen K. L., Biassoni R., Moretta A., Moretta L., Cambier J. C., and Vivier E. (1996) Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J. Immunol. 156, 4531–4534.PubMedGoogle Scholar
  13. 13.
    Le Dréan E., Vély F., Olcese L., Olivero S., Cambiaggi A., Guia S., Krystal G., Gervois N., Moretta A., Jotereau F., and Vivier E. (1998) Inhibition of antigeninduced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur. J. Immunol. 28, 264–276.PubMedCrossRefGoogle Scholar
  14. 14.
    Jönsson U. (1991) Real-time biospecific interaction analysis using surface plasmon resonance and sensor chip technology. BioTechniques 11, 620–627.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 1999

Authors and Affiliations

  • Frédéric Vély
    • 1
  • Alain Trautmann
    • 1
  • Eric Vivier
    • 2
  1. 1.Groupe Hospitalier Pitié-SalpétriéreLaboratoire d′Immunologie CellulaireParisFrance
  2. 2.Institut Universitaire de FranceMarseille-LuminyFrance

Personalised recommendations